INSIGHTS ON CLINICAL TRIAL DESIGN
-
Pharmacy Considerations For Early Phase Trials
This presentation explores practical pharmacy considerations in early-phase clinical trials, offering real-world insights from experienced clinical research pharmacists.
-
The Latest Generation Of Patient Recruitment Has Arrived
In the final session of our three-part webinar series, we explore what this next phase of evolution means for clinical trial planning and execution, and examine how innovative approaches are reshaping recruitment strategies from the ground up.
-
Key Takeaways From ADCs In Oncology Trials Webinar
By aligning cutting-edge design with evolving regulatory expectations, sponsors can unlock the full therapeutic potential of ADCs and deliver transformative cancer treatments to patients worldwide.
-
Managing Drug And Data Requirements In Decentralized Clinical Trials
Running a global decentralized clinical trial requires a deep understanding of the differences in FDA and EMA requirements for investigational products and patient data.
-
Inspection Facilitation Without Local MAH Presence5/26/2026
Local expertise and centralized oversight ensured compliant, well‑coordinated inspections across countries, reducing operational risk and client burden while maintaining consistent authority engagement.
-
Site Networks And Hybrid Solutions7/22/2025
Learn how community- and patient-centric site networks that have DCT capabilities are able to work with a broad-range of site types.
-
CNS Trials Are Difficult — Do They Have To Be?3/9/2026
Clinical trials for central nervous system therapies face significant obstacles to approval, including subjective endpoints and complex patient selection. Consider a strategic approach for success.
-
The Expanding Role Of GLP-1 Receptor Agonists In CNS Clinical Research7/31/2026
Metabolic drugs show promise for brain disorders. Emerging evidence suggests they reduce addictive behaviors and may help treat neurodegenerative diseases, opening new pathways for addiction and neurological care.
-
Why Operational Design Determines Recruitment And Retention4/22/2026
Patient recruitment challenges often receive the most attention in clinical trials, yet many enrollment and retention issues stem from operational friction embedded in study design.
CLINICAL TRIAL DESIGN SOLUTIONS
-
Veristat harnesses knowledge, expertise, and scale to provide superior solutions and progressive approaches to mitigate risks and achieve meaningful outcomes for biopharmaceutical and medical technology companies, and their patients.
-
Get an overview of this groundbreaking synthetic data product – uniquely derived from Medidata’s exclusive repository of global, standardized historical clinical trial data.
-
Mechanism-specific autoimmune treatments demand deeper biological insight. Discover how an integrated trial strategy improves signal detection.
-
Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
-
Learn how biospecimens, clinical data, cohort identification, and specialized laboratory services come together to support complex translational and biomarker research initiatives.